omega-n-methylarginine has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 214 | 5 | 58 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 2.1002 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
Elliott, GT; Jacobson, KA; Liang, BT; Stambaugh, K | 1 |
2 other study(ies) available for omega-n-methylarginine and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel.
Topics: Adenosine; Animals; Cells, Cultured; Chick Embryo; Ischemic Preconditioning, Myocardial; Lipid A; Myocardium; omega-N-Methylarginine; Pinacidil; Potassium Channels; Purinergic P1 Receptor Agonists; Vasodilator Agents | 1999 |